Xin Lin

2.4k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

Xin Lin is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Xin Lin has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 4 papers in Genetics. Recurrent topics in Xin Lin's work include Peptidase Inhibition and Analysis (7 papers), Protein Degradation and Inhibitors (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Xin Lin is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Protein Degradation and Inhibitors (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Xin Lin collaborates with scholars based in China, United States and South Korea. Xin Lin's co-authors include Xiaohong Chen, Jin Xie, Wei Tang, Zipeng Zhen, Guoshun Luo, Hua Xiang, Hongmin Chen, Trever Todd, Gang Liu and Taku Cowger and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and ACS Nano.

In The Last Decade

Xin Lin

24 papers receiving 1.8k citations

Hit Papers

Regulatory mechanisms of PD-1/PD-L1 in cancers 2024 2026 2025 2024 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Lin China 15 827 568 459 405 296 24 1.9k
Alexandre Detappe United States 22 887 1.1× 552 1.0× 357 0.8× 540 1.3× 232 0.8× 62 2.1k
Marta Truffi Italy 24 704 0.9× 394 0.7× 405 0.9× 379 0.9× 210 0.7× 69 1.7k
Sheela A. Abraham Canada 20 963 1.2× 483 0.9× 697 1.5× 285 0.7× 249 0.8× 47 1.9k
Tracy R. Daniels‐Wells United States 26 1.5k 1.8× 454 0.8× 644 1.4× 553 1.4× 400 1.4× 51 3.0k
Ehud Segal United States 21 987 1.2× 543 1.0× 375 0.8× 503 1.2× 61 0.2× 26 2.2k
Sharon A. Johnstone Canada 15 993 1.2× 450 0.8× 850 1.9× 251 0.6× 196 0.7× 20 1.7k
Yanlian Yang China 25 786 1.0× 592 1.0× 330 0.7× 332 0.8× 50 0.2× 82 1.8k
Elaine Westrick United States 19 937 1.1× 456 0.8× 542 1.2× 620 1.5× 54 0.2× 28 2.2k
Joseph A. Reddy United States 30 1.5k 1.8× 472 0.8× 764 1.7× 763 1.9× 93 0.3× 49 2.9k

Countries citing papers authored by Xin Lin

Since Specialization
Citations

This map shows the geographic impact of Xin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lin more than expected).

Fields of papers citing papers by Xin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lin. The network helps show where Xin Lin may publish in the future.

Co-authorship network of co-authors of Xin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Lin. A scholar is included among the top collaborators of Xin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Lin. Xin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Xin, Pan Chen, Zhaoyang Zeng, et al.. (2024). Regulatory mechanisms of PD-1/PD-L1 in cancers. Molecular Cancer. 23(1). 108–108. 273 indexed citations breakdown →
2.
Luo, Guoshun, et al.. (2022). Novel 11β-substituted estradiol conjugates: Transition from ERα agonizts to effective PROTAC degraders. The Journal of Steroid Biochemistry and Molecular Biology. 223. 106154–106154. 4 indexed citations
3.
Luo, Guoshun, Xin Lin, Shengnan Ren, et al.. (2021). Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer. European Journal of Medicinal Chemistry. 226. 113870–113870. 17 indexed citations
5.
Luo, Guoshun, et al.. (2020). Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator. European Journal of Medicinal Chemistry. 209. 112910–112910. 8 indexed citations
6.
Lin, Xin, et al.. (2020). Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer. Bioorganic & Medicinal Chemistry. 28(23). 115763–115763. 15 indexed citations
7.
Luo, Guoshun, Xin Lin, Xinyu Li, et al.. (2020). Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo. Acta Pharmaceutica Sinica B. 11(5). 1300–1314. 63 indexed citations
8.
Lin, Xin, Hua Xiang, & Guoshun Luo. (2020). Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance. European Journal of Medicinal Chemistry. 206. 112689–112689. 67 indexed citations
9.
Lin, Xin, Xiang Lu, Guoshun Luo, & Hua Xiang. (2019). Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules. European Journal of Medicinal Chemistry. 186. 111876–111876. 121 indexed citations
10.
Wei, Tianxiang, et al.. (2018). Near-infrared MnCuInS/ZnS@BSA and urchin-like Au nanoparticle as a novel donor-acceptor pair for enhanced FRET biosensing. Analytica Chimica Acta. 1042. 71–78. 26 indexed citations
11.
Li, Xinyu, Xin Lin, Linyi Liu, et al.. (2018). Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ERα and VEGFR-2. European Journal of Medicinal Chemistry. 161. 445–455. 30 indexed citations
12.
Jiang, Changying, Yifan Zhu, Zhifen Zhou, et al.. (2016). TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression. Oncogene. 36(20). 2813–2823. 37 indexed citations
13.
Zhen, Zipeng, Wei Tang, Yen‐Jun Chuang, et al.. (2014). Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles. ACS Nano. 8(6). 6004–6013. 211 indexed citations
14.
Zhen, Zipeng, Wei Tang, Cunlan Guo, et al.. (2013). Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer. ACS Nano. 7(8). 6988–6996. 239 indexed citations
15.
Lin, Xin, Jin Xie, Lei Zhu, et al.. (2011). Hybrid Ferritin Nanoparticles as Activatable Probes for Tumor Imaging. Angewandte Chemie. 123(7). 1607–1610. 14 indexed citations
16.
Lin, Xin, Jin Xie, Gang Niu, et al.. (2011). Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging. Nano Letters. 11(2). 814–819. 216 indexed citations
17.
Lin, Xin, Jin Xie, Lei Zhu, et al.. (2011). Hybrid Ferritin Nanoparticles as Activatable Probes for Tumor Imaging. Angewandte Chemie International Edition. 50(7). 1569–1572. 117 indexed citations
18.
Quan, Qimeng, Min Yang, Haokao Gao, et al.. (2011). Imaging tumor endothelial marker 8 using an 18F-labeled peptide. European Journal of Nuclear Medicine and Molecular Imaging. 38(10). 1806–1815. 7 indexed citations
19.
Niu, Gang, et al.. (2011). Imaging tumor-induced sentinel lymph node lymphangiogenesis with LyP-1 peptide. Amino Acids. 42(6). 2343–2351. 1 indexed citations
20.
Lin, Xin, Jin Xie, & Xiaohong Chen. (2010). Protein-based tumor molecular imaging probes. Amino Acids. 41(5). 1013–1036. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026